Skip to main content

Advertisement

SpringerLink
Log in

Update gastroenterologie 1997 — Teil I

  • Update
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Agreus L, Engstrand L, Svärdsudd K et al. Helicobacterpylori seropositivity among Swedish adults with and without abdominal symptoms. Scand J Gastroenterol 1995; 30: 752–7.

    Article  PubMed  CAS  Google Scholar 

  2. Agreus L, Svärdsudd K, Nyren O et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109:671–80.

    Article  PubMed  CAS  Google Scholar 

  3. Barbaro G, Barbarini G, Calderon W et al. Fluconazole versus itraconazole for Candida esophagitis in acquired immunodeficiency syndrome. Gastroenterology 1996; 111:1169–77.

    Article  PubMed  CAS  Google Scholar 

  4. Baretton GB, Diebold J, Christoforis G, et al. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Cancer 77(1996) 255–64

    Article  PubMed  CAS  Google Scholar 

  5. Baretton GB, Vogt M, Müller C, et al. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II). Scand J Gastroenterol 1996; 31: 481–9.

    Article  PubMed  CAS  Google Scholar 

  6. Bate CM, Booth SN, Crowe JP, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux ösophagitis. Gut 1995;36:492–8.

    Article  PubMed  CAS  Google Scholar 

  7. Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;354: 1591–4.

    Article  Google Scholar 

  8. Bayless TM, Tokayer AZ, Polito JM, et al. Crohn’s disease: concordance for site and clinical type in affected family members — potential hereditary influences. Gastroenterology 1996;111:573–9.

    Article  PubMed  CAS  Google Scholar 

  9. Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med 1996;334:1557–60.

    Article  PubMed  CAS  Google Scholar 

  10. Benhattar J, Cerottini JP, Saraga E, et al. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int J Cancer 1996;69:190–2.

    Article  PubMed  CAS  Google Scholar 

  11. Bennett MA, Kay EW, Mulcahy H, et al. Ras and p53 in the prediction of survival in Dukes’ stage B colorectal carcinoma. J Clin Pathol 1995;48:M310–5.

    Article  CAS  Google Scholar 

  12. Blaser MJ, P.H. Chyou PH, A. Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995;55:562–5.

    PubMed  CAS  Google Scholar 

  13. Bor-Shyang Sheu, Xi-Zhang Lin, Ching-Yih, Shu-Ghu Shiesh. Is triple therapy beneficial to patients with Helicobacter pylori related nonulcer dyspepsia? Gut 1995; 37:A9.

    Google Scholar 

  14. Bouhnik Y, Léman M, Mary JY, et al. Long-term follow-up of patients with Crohn’s disease treated with azathioprine or 6-mercaptopurine. Lancet 1996;347:215–9.

    Article  PubMed  CAS  Google Scholar 

  15. Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn’s disease. Gastroenterology 1995;108:345–9.

    Article  PubMed  CAS  Google Scholar 

  16. Burgh van der A, Dees J, Hop WCJ, et al. Ösophageal cancer is an uncommon cause of death in patients with Barrett’s ösophagus. Gut 1996;39:5–8.

    Article  PubMed  Google Scholar 

  17. Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short-bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg 1995;222:243–55.

    Article  PubMed  CAS  Google Scholar 

  18. Caballero-Plasencia AM, Muros-Navarro MC, Marin-Ruiz JL, et al. Dyspeptic symptoms and gastric emptying of solids in patients with functional dyspepsia. Role of Helicobacter pylori infection. Scand J Gastroenterol 1995;30:745–51.

    Article  PubMed  CAS  Google Scholar 

  19. Candy S, Wright J, Gerber M, et al. Controlled double blind study of azathioprine in the managment of Crohn’s disease. Gut 1995;37:674–8.

    Article  PubMed  CAS  Google Scholar 

  20. Caspary WF, Arnold R, Bayerdörffer E, et al. Diagnostik und Therapie der Helicobacter-pylori-Infektion. Z Gastroenterol 1996;34:392–401.

    PubMed  CAS  Google Scholar 

  21. Chauhan A, Petch MC, Schofield PM. Cardio-oeosphageal reflex in humans as a mechanism for ‘linked angina’. Eur Heart J 1996;17:407–13.

    PubMed  CAS  Google Scholar 

  22. Chitkara YK, McCasland KA, Kenefic L. Development and implementation of cost-effective guidelines in the laboratory investigation of diarrhö in a community hospital. Arch Int Med 1996;156:1445–8.

    Article  CAS  Google Scholar 

  23. Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med 1994;236:619–32.

    Article  PubMed  CAS  Google Scholar 

  24. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in Critically Ill Patients. JAMA 1996;275:308–14.

    Article  PubMed  CAS  Google Scholar 

  25. Cutler AF, Havstad S, Ma CK, et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109:136–41.

    Article  PubMed  CAS  Google Scholar 

  26. Dryden MS, Gabb SK, Wright RJE. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996;22:1019–25.

    PubMed  CAS  Google Scholar 

  27. Ekström P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous nonsteroidal antiinflammatory drug therapy. Scand J Gastroenterol 1996;31:753–8.

    Article  PubMed  Google Scholar 

  28. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn’s disease. N Engl J Med 1995;332:292–7.

    Article  PubMed  CAS  Google Scholar 

  29. Field KS, Unterwood M, Brant R, et al. Prevalence of gastroösophageal reflux symptoms in asthma. CHEST 1996;109:316–22.

    Article  PubMed  CAS  Google Scholar 

  30. Fine KD. The prevalence of occult gastrointestinal bleeding in celiac sprue. N Engl J Med 1996;18:1163–7.

    Article  Google Scholar 

  31. Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995;76:1116–9.

    Article  PubMed  CAS  Google Scholar 

  32. Genta RM, Gürer IE, Graham DY, et al. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 1996; 111:1206–11.

    Article  PubMed  CAS  Google Scholar 

  33. Giovannucci E, Ascherior A, Rimm EB, et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995;122:327–34.

    PubMed  CAS  Google Scholar 

  34. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609–14.

    Article  PubMed  CAS  Google Scholar 

  35. Glasbrenner B, Malfertheiner P, Nilius M, et al. Prevalence of Helicobacter pylori infection and dyspepsia in young adults in Germany. Z Gastroenterol 1996;34:478–82.

    PubMed  CAS  Google Scholar 

  36. Goh HS, Yao J, Smith DR. p53 point mutation and survival in colorectal cancer patients. Cancer Res 1995;55: 5217–21.

    PubMed  CAS  Google Scholar 

  37. Goldstone AR, Quirke P, Dixon MF. Helicobacter pylori infection and gastric cancer. J Pathol 1996;179:129–37.

    Article  PubMed  CAS  Google Scholar 

  38. Gorfine SR. Treatment of benigne anal disease with topical nitroglycerin. Dis Colon Rectum 1995;38:453–7.

    Article  PubMed  CAS  Google Scholar 

  39. Gormally SM, Kierce BM, Daly LE, et al. Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori. Gut 1996;38:513–7.

    Article  PubMed  CAS  Google Scholar 

  40. Grant D. Current results of intestinal transplantation. Lancet 1996;347:1801–3.

    Article  PubMed  CAS  Google Scholar 

  41. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide as maintenance treatment for Crohn’s disease: A placebo-controlled, dose-ranging study. Gastroenterology 1996;110:45–51.

    Article  PubMed  CAS  Google Scholar 

  42. Gui D, Cassetta E, Anastasio G, et al. Botulinum toxin for chronic anal fissure. Lancet 1994;344:1127–8.

    Article  PubMed  CAS  Google Scholar 

  43. Hamlet A, Olbe L. The influence of Helicobacter pylori infection on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology 1996;111:391–400.

    Article  PubMed  CAS  Google Scholar 

  44. Hansson L-E, Nyren O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242–9.

    Article  PubMed  CAS  Google Scholar 

  45. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–7.

    Article  PubMed  CAS  Google Scholar 

  46. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroösophageal reflux: Acid suppressive therapy improves asthma outcome. Am J Med 1996;100:395–405.

    Article  PubMed  CAS  Google Scholar 

  47. Harria AW, Gummett PA, Misiewicz JJ, et al. Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin. Gut 1996;38:663–7.

    Article  Google Scholar 

  48. Harris AW, Gummett PA, Walker MM, et al. Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb. Gut 1996;39:513–20.

    Article  PubMed  CAS  Google Scholar 

  49. Hayashi N, Ito I, Yanagisawa A, et al. Genetic diagnosis of lymphnode metastasis in colorectal cancer. Lancet 1995; 345:1257–9.

    Article  PubMed  CAS  Google Scholar 

  50. Heinemann EF, Zahm H, McLaughlin JK, et al. Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of US veterans and a review. Int J Cancer 1995;59:728–38.

    Article  Google Scholar 

  51. Henry D, Lim LL-Y, Rodriguez LAG, et al. Variability in risk of gastrointestinal complications with individual non-sterodial antiinflammatory drugs: results of a collaborative metaanalysis. BMJ 1996;312:1563–6.

    PubMed  CAS  Google Scholar 

  52. Hill M, Norman A, Cunningham D, et al. Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer. J Clin Oncol 1995; 13:1297–1302.

    PubMed  CAS  Google Scholar 

  53. Imperiale TF, Speroff T, R. Bebul RC, et al. A cost analysis of alternative treatments for duodenal ulcer. Ann Intern Med 1996;123:665–72.

    Google Scholar 

  54. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345:939–44.

    Article  Google Scholar 

  55. Kahrilas PJ. Gastroösophageal reflux disease. JAMA 1996;276:983–8.

    Article  PubMed  CAS  Google Scholar 

  56. Kanda T, Fujii H, Murakami H, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996;110:339–43.

    Article  PubMed  CAS  Google Scholar 

  57. Khulusi S, Badve S, Patel P, et al. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology 1996;110:452–8.

    Article  PubMed  CAS  Google Scholar 

  58. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood-test. Lancet 1996;348:1467–71.

    Article  PubMed  CAS  Google Scholar 

  59. Kuipers EJ, Lundell DL, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:18–22.

    Article  Google Scholar 

  60. Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996;110: 725–32.

    Article  PubMed  CAS  Google Scholar 

  61. Lanas AI, Remacha B, Esteva F, et al. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995;109:1124–33.

    Article  PubMed  CAS  Google Scholar 

  62. Lankisch PG, Schramm AM, Peterson A, et al. Diagnostic intervals for recognizing celiac disease. Z Gastroenterol 1996;34:473–7.

    PubMed  CAS  Google Scholar 

  63. Laukka MA, Cameron J, Schei AJ. Gaströsophageal reflux and chronic cough: Which comes first? J Clin Gastroenterol 1994;19:100–4.

    Article  PubMed  CAS  Google Scholar 

  64. Layer P, Brambs H-J, Ell C, et al. Update Gastroenterologie 1995 — Teil I. Med Klin 1995;90:701–8.

    CAS  Google Scholar 

  65. Layer P, Brambs H-J, Ell C, et al. Update Gastroenterologie 1995 — Teil II. Med Klin 1996;91:20–7.

    CAS  Google Scholar 

  66. Locke GR, Talley NJ, Carpenter HA, et al. Changes in the site and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology 1995;109: 1750–6.

    Article  PubMed  Google Scholar 

  67. Löfberg R, Danielsson A, Suhr O, et al. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology 1996;110: 1713–8.

    Article  PubMed  Google Scholar 

  68. Löfberg R., Rutgeerts P, Malchow H, et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn’s disease. A placebo controlled one year study. Gut 39(1996) 82–86

    Article  PubMed  Google Scholar 

  69. Maxton DG, Morris J, Whorwell PJ. Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia? Aliment Pharm Ther 1996;10:595–9.

    Article  CAS  Google Scholar 

  70. McDougall NI, Johnston BT, Kee F et al. Natural history of reflux ösophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996;38:481–6.

    Article  PubMed  CAS  Google Scholar 

  71. McFarlane XA., Bhalla AK, Robertson DAF. Effect of a gluten free diet on osteopenia in adults with newly diagnosed coeliac disease. Gut 1996;39:180–4.

    Article  PubMed  CAS  Google Scholar 

  72. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalam: ne treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology 1995;109:404–13.

    Article  PubMed  CAS  Google Scholar 

  73. Modigliani R, Colombel JF, Dupas JL, et al. Mesalamine in Crohn’s disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance. Gastroenterology 1996;110:688–93.

    Article  PubMed  CAS  Google Scholar 

  74. Moertel CG, Fleming TR, MacDonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321–6.

    PubMed  CAS  Google Scholar 

  75. Moser R, Hausmaninger H, Ludwig H, et al. 5-Fluorouracil and folinic acid with or without interferon in the treatment of metastatic colorectal cancer: preliminary results of a multicenter prospective randomized phase-III trial. Onkologie 1995;18:131–5.

    Article  Google Scholar 

  76. Müller-Lissner SA, Bavarian Constipation Study Group. Cisapride in chronic idiopathic constipation: Can the colon be re-educated? Eur J Gastroenterol Hepatol 1995; 7:69–73.

    PubMed  Google Scholar 

  77. Murray FE, Hudson N, Atherton JC, et al. Comparison of effects of calcium carbasalate and aspirin on gastroduodenal mucosal damage in human volunteers. Gut 1996;38:11–4.

    Article  PubMed  CAS  Google Scholar 

  78. Muta H, Nogucchi M, Perucho M, et al. Clinical implications of microsatellite instability in colorectal cancer. Cancer 1996;77:265–70.

    Article  PubMed  CAS  Google Scholar 

  79. Olbe L, Hamlet A, Dalenbäck J, et al. A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 1996;110:1386–94.

    Article  PubMed  CAS  Google Scholar 

  80. Oren R, Arber N, Odes S, et al. Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology 1996;110:1416–21.

    Article  PubMed  CAS  Google Scholar 

  81. Panos MZ, Walt RP, Stevenson C, et al. Rising death rate from non-malignant disease of the ösophagus (NMOD) in England and Wales. Gut 1995;36:488–91.

    Article  PubMed  CAS  Google Scholar 

  82. Parsonnet J. Helicobacter pylori in the stomach — a paradox unmasked. N Engl J Med 1996;335:278–80.

    Article  PubMed  CAS  Google Scholar 

  83. Pasricha PJ, Ravich WJ, Hendry TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasi. N Engl J Med 1995;322:774–8.

    Article  Google Scholar 

  84. Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996;10:83–9.

    Article  PubMed  CAS  Google Scholar 

  85. Persson PG, Bernell O, Leijonmarck CE, et al. Survival and cause-specific mortality of inflammatory bowel disease: a population-based cohort study. Gastroenterology 1996;110:1339–45.

    Article  PubMed  CAS  Google Scholar 

  86. Pitkäjärvi T, Kujanne E, Silliantaka I, Lumio J. Norfloxacin and salmonella excretion in acute gastroenteritis-a 6-month follow-up study. Scand J Infect Dis 1996;28:177–80.

    Article  PubMed  Google Scholar 

  87. Porro GB, Parente V, Imbesi, et al. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longtem NSAID users. Response to omeprazole dual therapy. Gut 1996;39:22–6.

    Article  CAS  Google Scholar 

  88. Raskin JB, White H, Jaszewski R, et al. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Am J Gastroenterol 1996;9:223–7.

    Google Scholar 

  89. Raskin JB, White RH, Jackon JE et al. Misoprostol dosage in the prevention of nonsteroidal antiinflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 1995;123:334–50.

    Google Scholar 

  90. Rensch MJ, Merenich JA, Lieberman M, et al. Glutensensitive enteropathy in patients with insulin-dependent diabetes mellitus. Ann Int Med 1996;124:564–77.

    PubMed  CAS  Google Scholar 

  91. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa associated lymphoid tissue. Ann Intern Med 1995;122:767–9.

    PubMed  CAS  Google Scholar 

  92. Rosenstock SJ, Andersen LP, Ka L, et al. Helicobacter pylori and gastrointestinal symptoms: Is there a relationship? Gut 1995;37:A 193.

    Google Scholar 

  93. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology 1995; 108:1617–21.

    Article  PubMed  CAS  Google Scholar 

  94. Saltissi S. Cardio-ösophageal reflux and ‘linked angina’—is the way to a man’s (or woman’s) heart through the stomach? Eur Heart J 1996;17:329–31.

    PubMed  CAS  Google Scholar 

  95. Sandborn WJ, Van Os EC, Zins BJ, et al. An intravenous loading dose of azathioprine decreases the time of response in patients with Crohn’s disease. Gastroenterology 1996;109:1808–17.

    Article  Google Scholar 

  96. Savarino V, Mela GS, Zentilin P, et al. Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. Gut 1996;39: 508–12.

    Article  PubMed  CAS  Google Scholar 

  97. Scheppach W, German-Austria SACFA Study Group. Treatment of distal ulcerative colitis with short-chain fatty acid enemas. Dig Dis Sci 1996;41:2254–9.

    Article  PubMed  CAS  Google Scholar 

  98. Shaker R, Milbrath M, Ren J, et al. Esophagoryngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 1995;109:1575–82.

    Article  PubMed  CAS  Google Scholar 

  99. Sharma SS, Bhargava N, Mathur SC. Effect of oral erythromycin on colonit transit in patients with idiopathic constipation. Dig Dis Sci 1995;40:2446–9.

    Article  PubMed  CAS  Google Scholar 

  100. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996;110:72–83.

    Article  PubMed  CAS  Google Scholar 

  101. Simon DM, Cello JP, Valenzuela J, et al. Multicenter trial of octrotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhöa. Gastroenterology 1995;108: 1753–60.

    Article  PubMed  CAS  Google Scholar 

  102. Sipponen P, Kosunen TU, Samloff IM, et al. Rate of Helicobater pylori acquisition among Finnish adults. Scand J Gastroenterol 1996;31:229–32.

    Article  PubMed  CAS  Google Scholar 

  103. Slattery J, Warlow CP, Shorrock CJ, et al. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin — analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1996;37:509–11.

    Article  Google Scholar 

  104. Sonnenberg A, Townsend WF. Costs of duodenal ulcer therapy with antibiotics. Arch. Intern Med 1995;155: 922–8.

    Article  PubMed  CAS  Google Scholar 

  105. Stange EF, Modigliani R, Pena AS, et al. European trial of cyclosporine in chronic active Crohn’s disease: a 12-month study. Gastroenterology 1995;109:774–82.

    Article  PubMed  CAS  Google Scholar 

  106. Stefanini GF, Saggioro A, Alvisi V, et al. Oral cromoly sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol 1995;30:535–41.

    Article  PubMed  CAS  Google Scholar 

  107. Sung JJY, Chung S, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139–42.

    Article  PubMed  CAS  Google Scholar 

  108. Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl Med 1996;334:1435–9.

    Article  CAS  Google Scholar 

  109. Thomas GAO, Rhodes J, Ragunath K, et al. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Eur J Gastorenterol Hepatol 1996;8:769–76.

    CAS  Google Scholar 

  110. Thompson NP, Driscoll R, Pounder RE, et al. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 1996;312:95–6.

    PubMed  CAS  Google Scholar 

  111. Vaezi MF, Richter JE. Role of acid and duodenogaströsophageal reflux in gastroösophageal reflux disease. Gastroenterology 1996;11:1192–9.

    Article  Google Scholar 

  112. Van Dullemen H, Van Deventer SJH, Hommes DW, et al. Treatment of Crohn’s disease with antitumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129–35.

    Article  PubMed  Google Scholar 

  113. Vazquez H, Cabanne A, Sugai E, et al. Serological markers identify histologically latent coeliac disease among firstdegree relatives. Eur J Gastroenterol Hepatol 1996;8:15–21.

    Article  PubMed  CAS  Google Scholar 

  114. Verdu EF, Armstrong D, Idström J-P, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995;37: 743–8.

    Article  PubMed  CAS  Google Scholar 

  115. Verdù EF, Fraser R, Tiberio D, et al. Prevalence of Helicobacter pylori infection and chronic dyspetic symptoms among immigrants from developing countries and people born in industrialized countries. Digestion 1996;57:180–5.

    Article  PubMed  Google Scholar 

  116. Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995;333:1106–10.

    Article  PubMed  CAS  Google Scholar 

  117. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–7.

    Article  PubMed  CAS  Google Scholar 

  118. Waring JP, Lacayo L, Hunter J, Katz E, et al. Chronic cough and hoarseness in patients with severe gastroösophageal reflux disease. Diagnosis and response to therapy. Dig Dis Sci 1995;40:1093–7.

    Article  PubMed  CAS  Google Scholar 

  119. Weil J, Colin-Jones D, Langman M, et al. Propylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310:827–30.

    PubMed  CAS  Google Scholar 

  120. Wenisch C, B. Parschalk, M. Hasenhündl, et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of clostridium difficile-associate diarrhea. Clin Infect Dis 1996;22:813–8.

    PubMed  CAS  Google Scholar 

  121. Wilcox MH, Howe R. Diarrhöa caused by clostridium difficile: response time for treatment with metronidazole and vancomycin. J Antimicrob Chemothe 1995;36:673–9.

    Article  CAS  Google Scholar 

  122. Wilke HJ, Fink U. Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction. N Engl J Med 1996;335:509–10.

    Article  PubMed  CAS  Google Scholar 

  123. Yousfi MM, El-Zimaity HMT, Cole RA, et al. Detection of Helicobacter pylori by rapid urease tests: Is biopsy size a critical variable? Gastrointeset Endosc 1996;43:222–4.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. II. Medizinische Klinik, Klinikum Aschaffenburg, Am Hasenkopf, D-63739, Aschaffenburg

    Wolfgang Fischbach

  2. I. Medizinische Klinik, Universitätsklinikum Regensburg, Regensburg, Deutschland

    Volker Groß & Jürgen Schölmerich

  3. Medizinische Klinik I, Universitätsklinikum Erlangen, Erlangen, Deutschland

    Christian Ell

  4. Abteilung für Gastroenterologie, Zentrum für Innere Medizin, Universitätsklinikum Essen, Essen, Deutschland

    Peter Layer

  5. Klinik und Poliklinik für Innere Medizin, Martin-Luther-Universität Halle-Wittenberg, Halle-Wittenberg, Deutschland

    Wolfgang E. Fleig

  6. Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg, Regensburg, Deutschland

    Hubert Zirngibl

Authors
  1. Wolfgang Fischbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Volker Groß
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jürgen Schölmerich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christian Ell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter Layer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wolfgang E. Fleig
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hubert Zirngibl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fischbach, W., Groß, V., Schölmerich, J. et al. Update gastroenterologie 1997 — Teil I. Med Klin 93, 70–80 (1998). https://doi.org/10.1007/BF03043280

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03043280

Search

Navigation